Security record · archived quarter
QDEL
QuidelOrtho Corporation · Healthcare · Medical - Specialties
11Tracked holders
—Δ holders
4.30MShares held
$142.83MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 84 | +5 | 50.81M | $890.20M | +12 | −7 |
| Q1 2026 | 82 | -2 | 47.90M | $787.78M | +7 | −10 |
| Q4 2025 | 85 | -1 | 49.13M | $1.40B | +2 | −2 |
| Q3 2025 | 15 | 0 | 30.61M | $901.42M | +1 | −2 |
| Q2 2025 | 13 | -1 | 30.01M | $864.94M | +1 | −2 |
| Q1 2025 | 11 | -2 | 9.03M | $313.14M | — | −2 |
| Q4 2024 | 13 | 0 | 9.23M | $411.10M | — | — |
| Q3 2024 | 12 | +1 | 5.88M | $267.97M | +2 | −1 |
| Q2 2024 | 11 | — | 4.30M | $142.83M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | D. E. Shaw & Co. ✦ | 1.56M | — | $51.71M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 1.56M | — | $51.71M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 904.64K | — | $30.06M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 904.64K | — | $30.06M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 612.55K | — | $20.35M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 406.34K | — | $13.50M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 254.22K | — | $8.41M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 254.22K | — | $8.41M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 254.22K | — | $8.41M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | GAMCO Investors ✦ | 223.09K | — | $7.41M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 143.59K | — | $4.77M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 104.41K | — | $3.47M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 40.84K | — | $1.36M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 40.84K | — | $1.36M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 40.11K | — | $1.33M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 13.71K | — | $455,280 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 232 holders, 80.48M shares, $1.22B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 14
SC 13G/A — T. Rowe Price Investment Management…
Aug 14
SC 13G/A — Newtyn Management, LLC
Aug 13
SC 13G — Invesco Ltd.
Aug 05
SC 13G/A — Neuberger Berman Group LLC
Jul 08
SC 13G — Neuberger Berman Group LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API